
New analysis tracks life-years gained from blood cancer therapies, revealing breakthrough inflection points, stubborn AML gaps, and inequities in access.
E. Anders Kolb, MD, is a world-renowned pediatric hematologist oncologist and researcher, is president and chief executive officer of Blood Cancer United.

New analysis tracks life-years gained from blood cancer therapies, revealing breakthrough inflection points, stubborn AML gaps, and inequities in access.

E. Anders Kolb, MD, on blood cancer research's legacy in oncology and the racial, geographic barriers still limiting patient access to care.

Learn why "life years saved" better captures progress in blood cancer than 5-year survival rates, with insights from Dr. E. Anders Kolb of Blood Cancer United.

Discover how genomics, trial-first care, and global advocacy speed safer, targeted treatments for pediatric leukemia—beyond survival to lifelong health.

September 18th 2026

May 6th 2026